A combination of geneType™ tests for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type 2 diabetes in a single test.
Know your patient’s risk of a serious disease to tailor a personalised prevention plan.
Knowing your patients’ personalised risk enables you to develop a health plan with them to reduce their risk of serious disease. Select from the tests below to take the first step to managing your patients’ risk.
Find out if your patients are at increased risk of developing breast cancer
Find out if your patients are at increased risk of developing colorectal cancer
Find out if your patients are at increased risk of developing a wide range of cancers as well as coronary artery disease and type 2 diabetes
Find out which antidepressant and dose could maximise your patients’ response and minimise side effects
Find out if your patients are at increased risk of developing conditions such as glaucoma, melanoma or atrial fibrillation
Find out if your patients are at risk of developing severe COVID-19 symptoms
geneType™ provides a risk assessment report that will assist you in developing a personalized health plan for your patients.
Register as a provider; our team will provide clinical education and other resources as needed.
We will send kits to your clinic to have on hand.
Discuss geneType™ with your patient.
Would geneType™ help them qualify for additional risk reduction strategies?
Complete the Test Requisition form, collect a saliva sample from the patient with the collection kit provided and return both to Rhythm.
You will have the option to use a paper requisition, or a secure, compliant portal to complete the ordering process.
Leave the rest to us.
We will notify you when your patient’s results are ready.
You will have the option to request a consult with a genetic counsellor, whether to review your patient’s results and/or to follow-up with your patient, as needed.
To ensure our tests are of the highest clinical value, Rhythm Biosciences has enlisted the experience and expertise of senior scientific and medical leaders from around the world. They help us tailor our tests to reflect the strongest scientific evidence. Together can advance the field. personalised, preventative health solutions.
MBBCh MA DPhil FRACGP MRCGP
Research & Education Lead, Primary Care Integration, Victorian Comprehensive Cancer Centre Herman Chair of Primary Care Cancer Research, University of Melbourne
MBBS, MD, FRACP, FRCP, AGAF MWGO
Principal Fellow and Professor, Department of Medicine, University of Melbourne, and Head of Colorectal Medicine and Genetics, The Royal Melbourne Hospital
MD, MS, FACMG
Regional Medical Director, Center for Clinical Genetics & Genomics. Clinical Director, PSJH Population Health Genomics Program. Chair, Integrated Network Cancer Program, Professor of Genetics, St John Cancer Institute
We provide multiple levels of support through our 3rd party telehealth partner, DNA Visit.
When your patients’ results are ready you may request:
Our goal is to support both healthcare providers and patients through this journey. This is not a test-and-forget approach.
If you have technical questions, or questions around a patient’s clinical report or setting up your customized support plan our Medical Affairs Team is available to you.
The first step is to setup an account to trial geneType™ at your practice.
Accredited For Compliance With NPAAC Standards And ISO 15189